Brendan Jenkins /saigenci/ en SAiGENCI recruit recognised with prestigious award /saigenci/news/list/2023/05/18/saigenci-recruit-recognised-with-prestigious-award Professor Jenkins has been appointed as the Program Head for the Tumour Inflammation and Immunotherapy Program at the South Australian ImmunoGENomics Cancer Institute (SAiGENCI), which operates within the ³ÉÈË´óƬ’s Faculty of Health and Medical Sciences, and is supported by an alliance with the Central Adelaide Local Health Network (CALHN). May 18 2023 Debbie Wellington /saigenci/news/list/2023/05/18/saigenci-recruit-recognised-with-prestigious-award